BriaCell Therapeutics Corp.
BCTX
$4.52
$0.214.87%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 193.86% | -43.04% | 43.39% | 148.53% | -13.44% |
| Total Receivables | -- | -- | -- | 8.19% | -11.45% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 94.07% | -43.10% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 183.55% | -43.05% | 34.77% | 106.42% | -12.85% |
|
|
|||||
| Total Current Assets | 183.55% | -43.05% | 34.77% | 106.42% | -12.85% |
| Net Property, Plant & Equipment | -8.36% | -7.68% | -7.16% | -6.66% | -6.24% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -2.10% | -2.06% | -2.02% | -2.03% | -1.94% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -43.54% | 0.00% | -40.80% | 0.00% | 0.00% |
| Total Assets | 156.93% | -39.61% | 27.34% | 81.57% | -10.09% |
|
|
|||||
| Total Accounts Payable | -11.71% | -35.17% | 0.14% | -34.46% | 18.17% |
| Total Accrued Expenses | 9.84% | 71.24% | -33.96% | 361.95% | -69.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -3.98% | -16.60% | -8.14% | -17.21% | 4.86% |
|
|
|||||
| Total Current Liabilities | -3.98% | -16.60% | -8.14% | -17.21% | 4.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -52.05% | 20.49% | -53.74% | -19.41% | -47.11% |
| Total Liabilities | -9.24% | -13.70% | -14.72% | -17.54% | -8.43% |
|
|
|||||
| Common Stock & APIC | 15.11% | 0.00% | 8.21% | 10.03% | 4.16% |
| Retained Earnings | -6.02% | -7.34% | -7.81% | -6.28% | -6.89% |
| Treasury Stock & Other | 45.34% | 1.06% | 26.48% | 40.59% | 18.43% |
| Total Common Equity | 209.85% | -44.20% | 44.02% | 244.59% | -10.88% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 209.85% | -44.20% | 44.02% | 244.59% | -10.88% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -11.95% | -14.78% | -15.33% | -26.09% | -14.08% |
| Total Equity | 223.13% | -46.06% | 45.16% | 270.05% | -13.09% |
|
|
|||||